BANK VONTOBEL/PUT/EDWARDS LIFESCIENCES/75/0.1/20.06.25

BANK VONTOBEL/PUT/EDWARDS LIFESCIENCES/75/0.1/20.06.25 Stock

DE000VD49SS6

Real-time Boerse Frankfurt Warrants 07:45:57 2024-07-01 EDT
0.36 ^EUR	+9.09%

1 month

-29.79%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart EDWARDS LIFESCIENCES CORPORATION

Chart BANK VONTOBEL/PUT/EDWARDS LIFESCIENCES/75/0.1/20.06.25

Latest news about EDWARDS LIFESCIENCES CORPORATION

Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	06-20	MT
Edwards Lifesciences Corporation Announces Executive Changes	06-17	CI
Wolfe Research Adjusts Price Target on Edwards Lifesciences to $70 From $75	06-17	MT
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR	06-05	BU

More news

Quotes 5-day view

Date	Price	Change
24-07-01	0.36	+9.09%
24-06-28	0.33	0.00%
24-06-27	0.33	-17.50%
24-06-26	0.4	+2.56%
24-06-25	0.39	+5.41%

Real-time Boerse Frankfurt Warrants

Last update July 01, 2024 at 07:45 am

More quotes

Static data

Product type	Warrants
Buy / Sell	PUT
Underlying	EDWARDS LIFESCIENCES CORPORATION
Issuer	Vontobel
WKN	VD49SS
ISIN	DE000VD49SS6
Date issued	2024-04-30
Strike	75 $
Maturity	2025-06-20 (354 Days)
Parity	10 : 1
Emission price	0.43 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	0.53 €
Lowest since issue	0.32 €
Delta	-0.08x
Omega	2.753
Premium	49.09x
Gearing	34.56x
Moneyness	0.5381
Difference Strike	-15.61 $
Difference Strike %	-20.81%
Spread	0.01 €
Spread %	2.63%
Theoretical value	0.3750
Implied Volatility	62.04 %
Total Loss Probability	78.71 %
Intrinsic value	0.000000
Present value	0.3750
Break even	70.97 €
Theta	-0.01x
Vega	0.02x
Rho	-0.01x

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).

Sector

More about the company